Long-term effects of Semliki Forest virus infection in the mouse central nervous system

Neuropathology and Applied Neurobiology

Volumn 23, Issue 3, 1997, Pages 235-241

  Donnelly, S M ^a   Sheahan, B J ^b   Atkins, G J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cytokine; Demyelination; Interferon ; Multiple sclerosis; Neuropathogenesis; Reverse transcriptase polymerase chain reaction; Semliki forest virus; Tumour necrosis factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; DEMYELINATING DISEASE; MOUSE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMLIKI FOREST ALPHAVIRUS; SPINAL CORD INFECTION; VIRUS ENCEPHALITIS;

EID: 0030906714     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1997.tb01207.x     Document Type: Article

References (38)

1. Allen I, Brankin B. Pathogenesis of multiple sclerosis: the immune diathesis and the role of viruses. J Neuropathol Exp Neurol 1993; 52: 95-105
2. Atkins GJ, Balluz IM, Glasgow GM et al. Analysis of the molecular basis of neuropathogenesis of RNA viruses in experimental animals: relevance for human disease? Neuropathol Appl Neurobiol 1993; 20: 91-102
3. Atkins GJ, Mabruk MJEMF, Glasgow GM, Griffin AM, Sheahan BJ. Mechanisms of viral teratogenesis. Rev Med Virol 1995; 5: 75-86
4. Atkins GJ, Sheahan BJ, Semliki Forest virus neurovirulence mutants have altered cytopathogenicity for central nervous system cells. Infect Immun 1982; 36: 333-41
5. Atkins GJ, Sheahan BJ, Dimmock NJ. Semliki Forest virus infection of mice: a model for the genetic and molecular analysis of viral pathogenicity. J Gen Virol 1985; 66: 395-408
6. Atkins GJ, Sheahan BJ, Mooney DA. Pathogenicity of Semliki Forest virus for the rat central nervous system and primary rat neural cell cultures-possible implications for the pathogenesis of multiple sclerosis. Neuropathol Appl Neurobiol 1990; 16: 57-68
7. Baker D, O'Neill JK, Turk JL. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell Immunol 1991; 134: 505-10
8. Balluz IM, Glasgow GM, Killen HM, Mabruk MJEMF, Sheahan BJ, Atkins GJ. Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage. Neuropathol Appl Neurobiol 1993; 19: 233-9
9. Barrett PN, Sheahan BJ, Atkins GJ. Isolation and preliminary characterization of Semliki Forest virus mutants with altered virulence. J Gen Virol 1980; 49: 141-7
10. Bruce CB, Chapman J, Suckling AJ, Rumsby MG. Infection of rat brain primary cell cultures with an avirulent A7 strain of Semliki Forest virus. J Neurol Sci 1984; 66: 77-90
11. Chew-Lim M, Scott T, Webb HE. An ultrastructural study of cerebellar lesions induced in mice by three inoculations of Semliki Forest virus. Acta Neuropathol 1978; 41: 51-9
12. Eralinna JP, Soiluhanninen M, Roytta M et al. Facilitation of experimental allergic encephalomyelitis by irradiation and virus infection: role of inflammatory cells. J Neuroimmunol 1994; 55: 81-90
13. Kazakerley JK, Webb HE. Semliki Forest virus-induced immune mediated demyelination-adoptive transfer studies and viral persistence in nude mice. J Gen Virol 1987; 68: 377-86
14. Fazakerley JK, Pathak S, Scallan M, Amor S, Dyson H. Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons. Virology 1993; 195: 627-37
15. Gates MC, Sheahan BJ, Atkins GJ. The pathogenicity of the M9 mutant of Semliki Forest virus in immune-compromised mice. J Gen Virol 1994; 65: 73-80
16. Gates MC, Sheahan BJ, O'Sullivan MA, Atkins GJ. The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell cultures. J Gen Virol 1985; 66: 2365-73
17. Glasgow GM, Sheahan BJ, Atkins GJ, Wahlberg JM, Salminen A, Liljeström P. Two mutations in the envelope glycoprotein-E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice. Virology 1991; 185: 741-48
18. Hood L, Steinmetz M, Malissen B. Genes of the major histocompatibility complex of the mouse. Ann Rev Immunol 1982; 1: 529-68
19. Jackson AC, Moench TR, Trapp BD, Griffin DE. Basis of neurovirulence in Sindbis virus encephalitis of mice. Lab Invest 1988; 58: 503-9
20. Lando Z, Teitelbaum D, Arnon R. Induction of experimental allergic encephalomyelitis in genetically resistant strains of mice. Nature 1980; 287: 551-2
21. Levine B, Griffin DE. Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J Virol 1992; 66: 6429-35
22. Lindsey JW, Pappolla M, Steinman L. Reinduction of experimental autoimmune encephalomyelitis in mice. Cell Immunol 1995; 162: 235-40
23. Merrill JH, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman FM. Inflammatory leucocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci USA 1992; 89: 574-8
24. Mokhlarian F, Grob D, Griffin DE. Role of the immune response in Sindbis virus-induced paralysis of SJL/J mice. J Immunol 1989; 143: 633-7
25. Mokhtarian F, Shi Y, Zhu P, Grob D. Immune responses, and autoimmune outcome, during virus infection of the central nervous system. Cell Immunol 1994; 157: 195-210
26. Mokhtarian F, Swoveland P. Predisposition to EAE induction in resistant mice by prior infection with Semliki Forest virus. J Immunol 1987; 138: 3264-8
27. Mokhtarian F, Wesselingh SL, Choi S et al. Production and role of cytokines in the CNS of mice with acute viral encephalomyelitis. J Neuroimmunol 1996; 66: 11-22
28. Renno T, Lin J, Piccirillo C, Antel J, Owens T. Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL mice. J Neuroimmunol 1994; 49: 1-7
29. Renno T, Krakowski M, Piccirillo C, Lin J, Owens T. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. J Immunol 1995; 154: 944-53
30. Sheahan BJ, Barrett PN, Atkins GJ. Demyelination in mice resulting from infection with a mutant of Semliki Forest virus. Acta Neuropathol 1981; 53: 129-36
31. Sheahan BJ, Gates MC, Caffrey JF, Atkins GJ. Oligodendrocyte infection and demyelination produced in mice by the M9 mutant of Semliki Forest virus. Acta Neuropathol 1983; 60: 257-65
32. Sheahan BJ, Ibrahim MA, Atkins GJ. Demyelination of olfactory pathways in mice following intranasal infection with the avirulent A7 strain of Semliki Forest virus. Eur J Vet Path 1996; 2: 117-25
33. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985; 1: 1313-5
34. Smyth JMB, Sheahan BJ, Atkins GJ. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system-consequences in BALB/c and SJL mice. J Gen Virol 1990; 71: 2575-83
35. Subak-Sharpe I, Dyson H, Fazakerley J. In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. J Virol 1993; 67: 7629-33
36. Suckling AJ, Jagelman S, Illavia SJ, Webb HE. The effect of mouse strain on the pathogenesis of the encephalitis and demyelination induced by avirulent Semliki Forest virus infections. Br J Exp Path 1980; 61: 281-4
37. Tsunoda I, Fujinami RS. Two models for multiple scherosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol 1996; 55: 673-86
38. Wesselingh SL, Levine B, Fox RJ, Choi S, Griffin DE. Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J Immunol 1994; 152: 1289-97